Gavin McStay

Dr. Gavin McStay

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Biochimie
Verified
Journal Article
Closed access
AHAndrew P Halestrap
Andrew P Halestrap
Gavin McStayGavin McStay
Gavin McStay
SCSamantha J Clarke
Samantha J Clarke

1 March 2012 in Cell
Verified
Journal Article
Closed access
JCJerry Edward Chipuk
Jerry Edward Chipuk
Gavin McStayGavin McStay
Gavin McStay
ABArchana Bharti
Archana Bharti
TKTomomi Kuwana
Tomomi Kuwana
CCChristopher J. Clarke
Christopher J. Clarke
DGDouglas R. Green
Douglas R. Green

1 September 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SCSamantha J. Clarke
Samantha J. Clarke
Gavin McStayGavin McStay
Gavin McStay
AHAndrew P. Halestrap
Andrew P. Halestrap
Cyclosporin A (CsA) inhibits opening of the mitochondrial permeability transition pore (MPTP), a critical event in some forms of necrotic and apoptotic cell death, by binding to cyclophilin D (CyP-D) and inhibiting its peptidyl-prolylcis-trans isomerase (PPIase) activity. Sanglifehrin A (SfA), like CsA, exerts its immunosuppressive action by binding to cyclophilin A but at a different site from CsA, and unlike the latter, SfA does not inhibit calcineurin activity. Here we demonstrate that SfA inhibits the PPIase activity of CyP-D (K 0.5 2 nm) and acts as a potent inhibitor of MPTP opening under both energized and de-energized conditions. However, unlike CsA, the dose-response curve for inhibition by SfA is sigmoidal rather than hyperbolic, suggesting a multimeric structure for the MPTP with cooperativity between subunits. Furthermore, SfA does not prevent CyP-D binding to submitochondrial particles or detergent-solubilized adenine nucleotide translocase (ANT), implying that CyP-D binding to the ANT does not require PPIase activity but pore opening does. Once bound to the MPTP, SfA is not readily dissociated, and inhibition of pore opening is maintained following extensive washing. To investigate the potential of SfA as an inhibitor of cell death in vivo, we used the Langendorff perfused rat heart. SfA caused a time-dependent inhibition of the MPTP that was maintained on mitochondrial isolation to a greater extent than was CsA inhibition. We demonstrate that SfA, like CsA, improves the recovery of left ventricular developed pressure during reperfusion after 30 min of global ischemia and greatly reduces lactate dehydrogenase release, implying inhibition of necrotic damage. Because SfA does not inhibit calcineurin activity, our data suggest that it may be more desirable than CsA for protecting tissues recovering from ischemic episodes and for studying the role of the MPTP in cell death.

15 October 2002 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
Gavin McStayGavin McStay
Gavin McStay
SCSamantha J. Clarke
Samantha J. Clarke
AHAndrew P. Halestrap
Andrew P. Halestrap
Opening of the mitochondrial permeability transition pore (MPTP) is sensitized to [Ca2+] by oxidative stress (diamide) and phenylarsine oxide (PAO). We have proposed that both agents cross-link two thiol groups on the adenine nucleotide translocase (ANT) involved in ADP and cyclophilin-D (CyP-D) binding. Here, we demonstrate that blocking Cys160 with 80μM eosin 5-maleimide (EMA) or 500μM N-ethylmaleimide (NEM) greatly decreased ADP inhibition of the MPTP. The ability of diamide, but not PAO, to block ADP inhibition of the MPTP was antagonized by treatment of mitochondria with 50μM NEM to alkylate matrix glutathione. Binding of detergent-solubilized ANT to a PAO-affinity matrix was prevented by pre-treatment of mitochondria with diamide, EMA or PAO, but not NEM. EMA binding to the ANT in submitochondrial particles (SMPs) was prevented by pre-treatment of mitochondria with either PAO or diamide, implying that both agents modify Cys160. Diamide and PAO pre-treatments also inhibited binding of solubilized ANT to a glutathione S-transferase—CyP-D affinity column, both effects being blocked by 100μM EMA. Intermolecular cross-linking of adjacent ANT molecules via Cys57 by copper phenanthroline treatment of SMPs was abolished by pre-treatment of mitochondria with diamide and PAO, but not with EMA. Our data suggest that PAO and diamide cause intramolecular cross-linking between Cys160 and Cys257 directly (not antagonized by 50μM NEM) or using glutathione (antagonized by 50μM NEM) respectively. This cross-linking stabilizes the ‘c’ conformation of the ANT, reducing the reactivity of Cys57, while enhancing CyP-D binding to the ANT and antagonizing ADP binding. The two effects together greatly sensitize the MPTP to [Ca2+].

2 November 2007 in Cell Death & Differentiation
Verified
Journal Article
Closed access
Gavin McStayGavin McStay
Gavin McStay
GSG S Salvesen
G S Salvesen
DGD R Green
D R Green

7 October 2005 in Science
Verified
Journal Article
Closed access
PDF file
DSDiana C.J. Spierings
Diana C.J. Spierings
Gavin McStayGavin McStay
Gavin McStay
MSMaya Saleh
Maya Saleh
CBCheryl Bender
Cheryl Bender
JCJerry Edward Chipuk
Jerry Edward Chipuk
DGDouglas R. Green
Douglas R. Green
The mitochondrial pathway of apoptosis in vertebrates is dependent on the process of mitochondrial outer membrane permeabilization (MOMP), which leads to the release of proteins from the mitochondrial intermembrane space into the cytosol. “Upstairs” of this event are the Bcl-2 family proteins that regulate and mediate MOMP; “downstairs” is the activation of caspases that orchestrate the dismantling of the cell. In the Connections Map database at Science 's Signal Transduction Knowledge Environment (STKE), the pathways that define the mitochondrial pathway of apotosis are illustrated, with the bulk of control occurring “upstairs” of MOMP.